Trial Outcomes & Findings for Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation (NCT NCT02348684)
NCT ID: NCT02348684
Last Updated: 2021-03-03
Results Overview
Cardiac MRI parameters include Left Ventricular (LV) ejection fraction, LV mass (indexed), LV dimensions, extracellular volume (ECV), and late gadolinium enhancement (LGE).
COMPLETED
20 participants
day of MRI scan
2021-03-03
Participant Flow
Participant milestones
| Measure |
Radiation Therapy Groups
Risk groups based on dosimetric radiation parameters and eligibility criteria.
Radiation therapy groups: 3D Conformal Radiation Therapy (3DCRT) to breast/chestwall and regional lymph nodes with treatment between 2000 and 2009.
|
|---|---|
|
Overall Study
STARTED
|
20
|
|
Overall Study
COMPLETED
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Radiation Therapy Groups
n=20 Participants
Risk groups based on dosimetric radiation parameters.
Radiation therapy groups: Radiation Therapy treatment between 2000 and 2007.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=20 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
14 Participants
n=20 Participants
|
|
Age, Categorical
>=65 years
|
6 Participants
n=20 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=20 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=20 Participants
|
|
Region of Enrollment
United States
|
20 participants
n=20 Participants
|
PRIMARY outcome
Timeframe: day of MRI scanCardiac MRI parameters include Left Ventricular (LV) ejection fraction, LV mass (indexed), LV dimensions, extracellular volume (ECV), and late gadolinium enhancement (LGE).
Outcome measures
| Measure |
Radiation Therapy Groups
n=20 Participants
Risk groups based on dosimetric radiation parameters and eligibility criteria.
Radiation therapy groups: Radiation Therapy treatment between 2000 and 2009.
|
|---|---|
|
Cardiac MRI Parameters
LGE
|
0 number of patients
|
|
Cardiac MRI Parameters
LVEF, more than 1% outside normal range
|
0 number of patients
|
|
Cardiac MRI Parameters
LV mass (indexed), higher than normal
|
0 number of patients
|
|
Cardiac MRI Parameters
LV chamber dimensions, higher than normal
|
0 number of patients
|
|
Cardiac MRI Parameters
Total Myocardial ECV, above 30%
|
3 number of patients
|
SECONDARY outcome
Timeframe: the day of MRICorrelate cardiac MRI parameters with pre-treatment heart imaging and cardiac dose volume constraints as a measure of cardiac injury after partial heart irradiation in women with node positive breast cancer treated with surgery, anthracycline-based chemotherapy and regional nodal irradiation.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: The day of the MRITrial data will improve the understanding of cardiac function after radiotherapy and allow oncologists to start to define safe dose-volume constraints for the heart in women treated with regional nodal irradiation for breast cancer.
Outcome measures
Outcome data not reported
Adverse Events
Radiation Therapy Groups
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place